Literature DB >> 30291383

Association of miR-146a Gene Polymorphism at loci rs2910164 G/C, rs57095329 A/G, and rs6864584 T/C with Susceptibility to Kawasaki Disease in Chinese Children.

Luting Zha1, Shentang Li1, Xin Liu1, Zhuoying Li1, Jie Jiang1, Lihua Huang2, Zuocheng Yang3.   

Abstract

OBJECTIVE: To investigate the genetic association of miR-146a gene polymorphisms at loci rs2910164 G/C, rs57095329 A/G, and rs6864584 T/C in patients with Kawasaki disease (KD) and coronary artery lesions (CAL).
METHODS: There were 120 patients with KD and 126 healthy subjects in this study. The genotype of loci rs2910164 G/C, rs57095329 A/G, and rs6864584 T/C of miR-146a gene were detected by polymerase chain reaction-sequence-based typing.
RESULTS: For miR-146a gene polymorphisms at loci rs2910164 G/C, rs57095329 A/G, and rs6864584 T/C, there were no significant difference of genotype frequencies and allele frequencies between KD group and healthy control group, or between the IVIG-resistant group and IVIG-sensitive group (P > 0.05). In KD with coronary artery lesions (KD-CAL) group, the genotype frequencies of GG were higher than that in KD without coronary artery lesion (KD-WO) group at locus rs2910164 G/C polymorphisms of miR-146a gene (χ2 = 6.660, P = 0.036), patients with KD carried genotype of GG were at 3.636 times higher risk of getting coronary artery lesions than those of non-carriers (χ2 = 6.455, P = 0.018, OR = 3.636, 95%CI = 1.280-10.262). While there was no significant difference of allele frequency of G and C between KD-CAL group and KD-WO group (P > 0.05). In KD-CAL group, the allele frequency of A was higher than that in KD-WO group at locus rs57095329 A/G polymorphisms of miR-146a gene (χ2 = 4.745, P = 0.035), carriers with allele A were at 2.422 times higher risk of getting coronary artery lesions than those of non-carriers (χ2 = 4.745, P = 0.035, OR = 2.422, 95%CI = 1.073-5.465), while there was no significant difference of genotype frequency of AA, AG, and GG types between KD-CAL group and KD-WO group (P > 0.05). There was no significant difference of genotype frequencies of TT, TC, and CC types and allele frequencies of T and C types between KD-CAL group and KD-WO group at locus rs6864584 T/C polymorphisms of miR-146a gene (P > 0.05).
CONCLUSIONS: The significant association has been found between the genotype and allele frequency of the miR-146a gene loci rs2910164 G/C and rs57095329 A/G, the genotype GG of rs2910164 G/C, and allele A of rs57095329 A/G were risk factors for getting coronary artery lesions.

Entities:  

Keywords:  Gene polymorphism; Kawasaki disease; MiR-146a gene

Mesh:

Substances:

Year:  2018        PMID: 30291383     DOI: 10.1007/s00246-018-2002-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  4 in total

Review 1.  Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.

Authors:  E Sapountzi; L Fidani; A Giannopoulos; A Galli-Tsinopoulou
Journal:  Pediatr Cardiol       Date:  2022-07-30       Impact factor: 1.838

2.  Association of Polymorphisms in miR146a, an Inflammation-Associated MicroRNA, with the Risk of Idiopathic Recurrent Spontaneous Miscarriage: A Case-Control Study.

Authors:  Saeedeh Salimi; Saman Sargazi; Behrouz Mollashahi; Milad Heidari Nia; Shekoufeh Mirinejad; Mahdi Majidpour; Marzieh Ghasemi; Sara Sargazi
Journal:  Dis Markers       Date:  2022-04-30       Impact factor: 3.464

3.  Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease.

Authors:  Jun Zhang; Handan Tan; Qingfeng Cao; Guannan Su; Peizeng Yang
Journal:  Dis Markers       Date:  2021-10-08       Impact factor: 3.434

4.  Association of miR-181c/d gene locus rs8108402 C/T polymorphism with susceptibility to Kawasaki disease in Chinese children.

Authors:  Meiqing Yao; Qin He; Manqiong Yang; Zhixiang Wu; Ying Li; Min Kong; Zhijuan Kang; Lu Yi; Yanan Hu; Lihua Huang; Zhuoying Li; Zuocheng Yang
Journal:  Front Pediatr       Date:  2022-08-09       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.